News

Eagle Point Credit Management's Preferred Stock Moves Explained

Eagle Point Credit Management's Preferred Stock Moves Explained

Recent Stock Transactions by Eagle Point Credit Management

Eagle Point Credit Management LLC, along with its affiliate Eagle Point DIF GP I LLC, has caught attention with their recent sale of preferred stock in ACRES Commercial Realty Corp. (NYSE: ACR). This notable move, detailed in their latest filings, generated over $540,000 from their stock transactions.

The sales comprised both the 8.625% Series C Preferred Stock and the 7.875% Series D Preferred Stock. Specifically, Eagle Point entities sold around 6,675 shares of Series C at an average price of $25.21 each and 10,400 shares of Series D at an average price of $23.44 each. Shortly after that, they sold an additional 5,159 shares of Series C at an average price of $25.22 per share.

These sales occurred within a price range of $23.44 to $25.22 per share, totaling approximately $542,162. Despite these sales, Eagle Point Credit Management LLC and Eagle Point DIF GP I LLC still hold indirect interests in ACRES through various private investment funds they manage. However, both organizations have clarified that they do not possess beneficial ownership of the mentioned securities, as stated in their filing documentation.

If you’re looking for more detailed insights regarding the pricing of shares sold in these transactions, feel free to reach out to the reporting entities. The transactions received verification from Kenneth P. Onorio, who serves as the Chief Financial Officer for both Eagle Point Credit Management LLC and Eagle Point DIF GP I LLC.

Latest Developments at ACRES Commercial Realty Corp.

Shifting focus to ACRES Commercial Realty Corp., the company released its second-quarter results for this year, showing a reduction in its loan portfolio while actively working to improve the credit quality of its investments. The firm successfully handled a defaulted loan and is keeping a close watch on its real estate investments, including a potential student housing project at Florida State University.

In terms of financial performance, ACRES reported a GAAP net income of $1.7 million along with a solid book value per share of $27.20. As part of its growth strategy, ACRES is looking at possible asset sales and is considering reinstating dividends, indicating a potentially optimistic outlook for future revenue generation.

ACR's Performance and Strategic Considerations

Additionally, market insights reveal that ACR's stock has experienced significant volatility yet managed to achieve an impressive annual return of 91.25%. Investors examining ACRES Commercial Realty Corp. will find current market capitalization at $115.25 million while they assess its overall financial health.

A standout feature is ACR's perfect Piotroski Score of 9, which signifies strong operational efficiency and a solid financial foundation. In addition, the management's ongoing share buyback strategy suggests confidence in the company’s current undervaluation and aims to significantly enhance shareholder value. As of the latest evaluations leading up to Q2 2024, ACR's stock trades at a low Price/Book ratio of 0.27, making it appealing for those focused on value investing.

Regarding revenue, ACR achieved a growth of 13.82% over the past year, showcasing its ability to grow market share despite a quarterly revenue drop of 6.32% in Q2 2024. Overall, the company registered a solid return of 24.9% over the last three months, which aligns nicely with a year-to-date price total return of 65.8%.

Looking Forward for Eagle Point Credit Management and ACR

In conclusion, the recent preferred stock transactions by Eagle Point Credit Management mark a pivotal moment for ACRES Commercial Realty Corp. Investors and stakeholders will be keenly watching how these developments shape up as both entities respond to the changing landscape ahead.

Frequently Asked Questions

What preferred stock did Eagle Point sell?

Eagle Point sold shares of the 8.625% Series C Preferred Stock and the 7.875% Series D Preferred Stock.

What was the total sales amount for the preferred stock?

The total value of the sold securities amounted to approximately $542,162.

What is the GAAP net income reported by ACRES?

ACRES reported a GAAP net income of $1.7 million for the second quarter.

What is ACR's Price/Book ratio as of Q2 2024?

ACR's Price/Book ratio is 0.27, which may attract value investors.

Hello! What is the current performance trend for ACR's stock?

ACR has demonstrated a strong annual return of 91.25% and a year-to-date price total return of 65.8%.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Orthocell's Remplir™ Hits Record U.S. Sales in October

Updated Category News Views 163

Orthocell's October Surprise with Remplir™ Sales Well, isn't this a breath of fresh air? Orthocell Limited just reported a staggering rise in its U.S. Remplir™ sales for October 2026. We're talking 92 units shifting off the shelves, pulling in a tidy AU$279,000. That's an 84% leap compared to the average monthly sales of 50 units in Q1 FY27. It seems the company's...

Continue Reading
Bahrain's USD 3.89 Billion Investment Surge in 2026

Updated Category News Views 194

Bahrain's Bold Moves to Woo Global Investment Bahrain's never been one to tiptoe around, huh? With a whopping USD 3.89 billion on the line, the Kingdom's flashing its neon sign to investors: "Open for Business!" These Golden License projects aren't just a few shiny new ventures — they're bridging aviation logistics, real estate, and the tech sector. Talk about ambition....

Continue Reading
Aiper’s Black Friday Pool Deals Make a Splash

Updated Category News Views 207

Black Friday: A Pool Owner's Break It’s not every day you stumble upon savings like these—Aiper is throwing some meaty discounts this Black Friday, saving pool owners up to a juicy $550 off robotic cleaners. Imagine that! For anyone with a pool to maintain, these deals might just be the ticket to less grunt work and more time lounging with a cold drink in hand....

Continue Reading
Double Down for Veterans Raises $20 Million Goal

Updated Category News Views 219

Helping Veterans: A Call That Never Fades If there's one thing that never changes, it's the enduring need to support those who have served. Semper Fi & America's Fund has been at the forefront of this mission for over a decade, and their annual Double Down for Veterans Match Campaign is nothing short of a testament to unwavering commitment. Kicking off for the 15th time,...

Continue Reading
SICO Snags $1.6B in New Investor Mandates for 2026

Updated Category News Views 110

SICO Makes Waves with Massive New Business Wins Right out of the gate at the Gateway Gulf 2026 Forum, SICO's announcement of a whopping $1.6 billion in new business mandates had even the seasoned pros raising an eyebrow or two. There's nothing like a sweet billion-dollar figure to kickstart the day, huh? This isn't small change we're talking about; this is a tidal wave of...

Continue Reading
Blokees Joins 'MIKU WITH YOU 2026' Concert in China

Updated Category News Views 138

Blokees Partners with Iconic Virtual Star Hatsune Miku There's a new player cozying up in the world of virtual icons, and it's none other than Blokees. If you haven't heard, Blokees just dipped its toes into the buzzing waters of the Hatsune Miku fandom by becoming an official strategic partner at the 'MIKU WITH YOU 2026' concert in Shanghai. You could call this a step up...

Continue Reading
Investcorp's Strong 2026: A Deep Dive into Key Moves

Updated Category News Views 139

Diving into Investcorp's Robust 2026 Performance If you're clued into the investment scene, you'll know that a $65.2 billion asset base isn't small potatoes. At the Gateway Gulf 2026, Investcorp didn't just present numbers—they laid out a dramatic year of action packed with billion-dollar dreams. While the dust hasn't quite settled yet, the first nine months of the year...

Continue Reading
Ericsson's Drone Tech and Share Buybacks: Impact & Insight

Updated Category News Views 10

Ericsson's Latest Move into Drone Detection Brace yourself, folks! Ericsson is taking things to a whole new altitude, literally. They're bringing drone detection capabilities right to our mobile networks. It's like they're transforming our standard network towers into stealthy drone spotters. Think about a mobile network that not only keeps your calls from dropping but...

Continue Reading
Smart Salary Moves for S Corp Owners: Riggs Unpacks Insights

Updated Category News Views 303

Decoding the S Corp Salary Dance How much salary should the savvy owners of S corporations draw? It ain't a simple task or one-size-fits-all deal, folks. David Riggs spills the beans on HelloNation, sharing insights on this complex tango between drawing wages and raking in shareholder distributions. In the end, it’s about playing by the IRS rules—or risking a penalty...

Continue Reading
Termite Swarmers: Essential Clues and Action Steps

Updated Category News Views 181

Understanding the Intrusive Nature of Termite Swarmers When it comes to creepy crawlies wreaking havoc on your beloved abode, termites are the stealthy troublemakers you need to keep an eye out for. Just because you catch a glimpse of them doesn't mean the damage is obvious or minimal. Spotting the Culprits: Termites vs. Ants Identifying what you're up against is the...

Continue Reading

Top 5 Most Recently Viewed Articles

TC BioPharm Transitions From Nasdaq to OTC Markets for Growth

Updated Category News Views 232

TC BioPharm's Transition to OTC Markets TC BioPharm (Holdings) PLC, known for its innovative work in gamma-delta T cell therapies, has made a significant announcement regarding its market standing. The company, which has been publicly traded on Nasdaq, will be making a shift to the OTC Markets due to recent developments concerning its listing status. The transition...

Continue Reading
Analyzing President Trump's Impactful First 100 Hours in Office

Updated Category News Views 490

Overview of President Trump's First Days in Office Washington, DC, saw an energetic start as President Trump commenced his term. In this review, we highlight the notable actions taken during his initial 100 hours, underscoring his commitment to making significant changes. Executive Orders and Their Implications In the early hours of his presidency, President Trump...

Continue Reading
Interparfums, Inc. Expands Portfolio with Off-White Fragrance

Updated Category News Views 153

Interparfums, Inc. Expands Portfolio with Off-White Fragrance Interparfums, Inc. (NASDAQ: IPAR) is making waves in the fragrance industry with its recent acquisition of the Off-White brand names and trademarks for fragrance and cosmetic products. This strategic move comes through its majority-owned subsidiary, Interparfums SA, which is positioned to start leveraging these...

Continue Reading
Gain Therapeutics CEO to Highlight Innovations at Key Events

Updated Category News Views 46

Gain Therapeutics, Inc. (Nasdaq: GANX) hit the scene as a fresh player in the biotech world, but traders were skeptical. Back in 2024, they got buzzed for their potential to shake up treatments with their allosteric small molecule therapies, focusing on Parkinson's disease among other targets. And you know how it goes in this game; expectations can skyrocket or tank real...

Continue Reading
Aardvark Therapeutics Faces Securities Fraud Lawsuit

Updated Category News Views 36

Investors Gear Up for Legal Battle There's nothing quite like the sound of a gavel about to drop when a company gets tangled up in a securities fraud lawsuit. This time, Aardvark Therapeutics, Inc. is in the hot seat. Shareholders are ruffling their feathers, and they're ready to take the company to court over claims of misleading information. You know the drill: someone...

Continue Reading